Antibodies against a novel nucleolar and cytoplasmic antigen (p105-p42) present in the sera of patients with a subset of rheumatoid arthritis (RA) with signs of scleroderma

Clinical and Experimental Immunology

Volumn 114, Issue 2, 1998, Pages 301-310

  Labrador, M ^a   Alguero A ^a   Diaz C ^a   Geli, C ^a   Perez E ^a   Garcia Valero J ^a   Rodriguez Sanchez, J L ^a   Gelpi C ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Anti nucleolar antibodies; Autoantibodies; Biogenesis; Rheumatoid arthritis; Ribosomal; Scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; DACTINOMYCIN; IMMUNOGLOBULIN G ANTIBODY; METHIONINE; SULFUR 35;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOPRECIPITATION; MALE; NUCLEOLUS; POLYSOME; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERODERMA;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; ENDOPEPTIDASES; HELA CELLS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, IMMUNOELECTRON; PEPTIDE MAPPING; PRECIPITIN TESTS; SCLERODERMA, SYSTEMIC; TUMOR CELLS, CULTURED;

EID: 0031762703     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00725.x     Document Type: Article

References (38)

1. Tan EM, Chan EK, Sullivan KF, Ruhin RL. Antinuclear antibodies (ANAs). Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988; 47:121-44.
2. Reeder RH. rRNA synthesis in the nucleolus. Trends Genet 1990; 6:390-5.
3. Balzcon R. Autoantibodies as probes in cell and molecular biology. Proc Soc Exp Biol Med 1993; 204:138-54.
4. Pfeifle J, Anderer FA, Franke M. Characterization of nucleolar proteins as autoantigens using human autoimmune sera. Ann Rheum Dis 1986; 45:978-86.
5. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988; 31:525-32.
6. Reimer G, Scheer U, Peters JM, Tan EM. Immunolocation and partial characterization of a nucleolar autoantigen (Pm/Scl) associated with polymyositis/scleroderma overlap syndromes. J Immunol 1986; 137: 3802-8.
7. Gelpi C, Algueró A, Martinez MA, Vidal S. Juárez C, Rodríguez-Sánchez JL. Identification of protein components reactive with anti-Pm/Scl autoantibodies. Clin Exp Immunol 1990; 81:59-64.
8. Rodríguez-Sanchez JL, Gelpi C, Juarez C, Hardin JA. A new autoantibody in scleroderma that recognises a 90 kDa component of nucleolus-organizing region of chromatin. J Immunol 1987; 139:2579-84.
9. Chan EK, Imai H, Hamel JC, Tan EM. Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med 1991; 174:1239-44.
10. Reimer G, Rose KM, Scheer U, Tan EM. Autoantibody to RNA polymerase I in seleroderma sera. J Clin Invest 1987; 79:65-72.
11. Douvas AS, Achten M, Tan EM. Identification of a nuclear protein (Scl70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem 1979; 254:10514-22.
12. Juarez C, Vila JL, Gelpi C, Agustí M, Amengual MJ, Martinez MA, Rodríguez JL. Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunoabsorbent assay. Arthritis Rheum 1988; 31:108-15.
13. Okano Y, Medsger TA. Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum 1990; 33:1822-8.
14. Lischwe MA, Ochs RL, Reddy R, Cook RG, Yeoman LC, Tan EM, Reichlin M, Busch H. Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem 1985; 260:14304-10 .
15. Mimori T, Suganuma K, Tanami Y et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA 1995; 92:7267-71.
16. Desprès N, Talbot G, Plouffe B, Boire G, Menard HA. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest 1995; 95:1891-6.
17. Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ, Serre G. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995; 95:2672-9.
18. Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS. Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol 1993; 32:199-203.
19. Dèspres N, Boire G, Lopez-Longo FJ, Menard HA. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 1994; 21:1027-33.
20. Steen VD, Powel DL, Medsger TA Jr. Clinic correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31:196-203.
21. Forman MS, Nakamura M, Mimori T, Gelpi C, Hardin JA. Detection of antibodies to small cytoplasmic ribonucleoproteins using unlabeled cell extract. Arthritis Rheum 1985; 28:1256.
22. Olson MOJ, Orrick LR, Jones C, Buscq H. Phosphorylation of acid-soluble nucleolar proteins of Novikoff hepatoma ascites cells in vivo. J Biol Chem 1974; 249:2823.
23. Matsui S, Fuke M, Busch H. Fidelity of ribosomal ribonucleic acid synthesis by nucleoli and nucleolar proteins. Biochemistry 1977; 16:39.
24. Matter L, Schpfer K, Wilhelm JA, Nyffernegger T, Parisot RF, De Robertis EM. Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies: a diagnostic evaluation. Arthritis Rheum 1982; 25:1278.
25. Mimori T, Hardin JA, Steitz JA. Characterization of the DNA-binding protein antigen ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem 1986; 269:2274.
26. Fisher DE, Reeves WH, Conner GE, Blonel G, Kunkel HG. Pulse labelling of small nuclear ribonucleoproteins in vivo reveals distinct patterns of antigen recognition by human autoimmune antibodies. Proc Natl Acad Sci USA 1984; 81:3185-9.
27. Cleveland DW, Fischer SG, Kirschner MV, Laemmly UK. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem 1977; 252:1102-6.
28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nirocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350.
29. Olmsted JB. Affinity purification of antibodies from diazotized paper blots of heterogeneous protein samples. J Biol Chem 1981; 256: 11955.
30. Tan KM, Lerner RA. An immunological study of the tales of nuclear and nucleolar macromolecules during the cell cycle. J Mol Biol 1972; 68:107-14.
31. Montes JF, Estrada G, López-Tejero MD, Garcia-Valero J. Changes in the enterocyte cytoskeleton in newborn rats exposed to ethanol in utero. Gut 1996; 38:846-52.
32. Goldfarb DS. Nuclear transport: proliferating pathways. Current Biol 1997; 7:13-16.
33. Meier TU, Blobel G. Nopp 140 shuttles on tracks between nucleolus and cytoplasm. Cell 1942; 70:127-38.
34. Nigg EA, Baeuerle PA, Luhrmann R. Nuclear import-export: in search of signals and mechanism. Cell 1991; 66:15-22.
35. Mandell RB, Feldherr CM. Identification of two HSP70-related Xenopus oocyte proteins that arc capable of recycling across the nuclear envelope. J Biol Chem 1490; 111:1775-83.
36. Adam SA, Gerace L. Cytosolic proteins that specifically bind nuclear location signals are receptors tor nuclear import. Cell 1991; 66:837-47.
37. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989; 56:379-90.
38. Soulard M, Lagaye S, Della Valle V, Danon F, Larsen CJ, Barque JP. Nucleolar proteins identified in human cells as antigens by sera from dogs with autoimmune disorders. Exp Cell Res 1989; 182:482-98.